Blockage of CD226 completely abrogated the effect of TIGIT/PD-L1 in the tumor but did not impact IFN-γ-producing CD8+ T cell frequency in the tumor-draining lymph node,57 suggesting a unique interplay among CD226, TIGIT and PD-1 in the tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.